COMMUNIQUÉS West-GlobeNewswire

Update of financial guidance for 2024

06/11/2024 - 17:46

GN has throughout the year increased its earnings power and cash flow generation, leading to an upgrade of the guidance on free cash flow excl. M&A to “DKK >1,100 million” and a confirmation of the EBITA margin [...]

Interim Report Q3 2024: Further margin expansion and strong cash flow despite mixed growth across divisions

06/11/2024 - 17:54

Highlights The Hearing division continued to gain significant market share leading to 10% organic revenue growth, while the divisional profit margin increased by 5.9 percentage points to 34.8% The Enterprise division [...]

SYNDEO Medical Announces European MDR Approval for Two Product Brands

06/11/2024 - 17:59

ZAVENTEM, Belgium, Nov. 06, 2024 (GLOBE NEWSWIRE) -- SYNDEO Medical, a Belgium-based leader in diagnostic and interventional procedural solutions, announces that its two flagship product brands, SYNDEOPack [...]

SAFE - Sortie de redressement judiciaire pour Safe

06/11/2024 - 18:00

Sortie de redressement judiciaire pour Safe Fleurieux-sur-l’Arbresle - France - le 6 novembre 2024 à 18h . Safe SA et ses filiales annoncent être sorties de la procédure de redressement judiciaire par jugement du [...]

Zenith Labs: Embracing a Holistic Approach to Anti-Aging

06/11/2024 - 18:00

MCHENRY, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- The increasing demand for dietary supplements is indicative of a larger cultural shift toward holistic health practices. Analysts project that the market will grow from [...]

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

06/11/2024 - 14:00

– Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment – – On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – – Strong balance sheet [...]

Pliant Therapeutics to Participate in the Stifel Healthcare Conference

06/11/2024 - 14:00

SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief Financial Officer, and Greg Cosgrove, M.D. FCCP, will participate in a [...]

EDAP to Participate in the 2024 Jefferies London Healthcare Conference

06/11/2024 - 14:00

LYON, France, November 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and host 1x1 investor [...]

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency

06/11/2024 - 14:00

State-of-the-Art Pharmacy Completes LifeMD’s End-to-end Healthcare Platform, Supporting 5,000 Daily Orders, Improving Operating Margins, and Enabling Curated Care Journeys NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- [...]

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

06/11/2024 - 14:00

DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic [...]

Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

06/11/2024 - 14:00

PHILADELPHIA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed [...]

ARS Pharmaceuticals Announces Conference Call and Webcasts for its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences

06/11/2024 - 14:00

Third Quarter Earnings Conference Call to be Held on November 13 at 8:00 a.m. ET SAN DIEGO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc . (Nasdaq: SPRY), a biopharmaceutical company dedicated to [...]

Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections

06/11/2024 - 14:00

Trial reaches dosing milestone, with 20 of the 30 total patients dosed All patients dosed met the primary endpoints of the study, either a cure or notable improvement following treatment with RECCE ® 327 topical gel ( [...]

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

06/11/2024 - 14:00

CONSHOHOCKEN, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences: UBS Global [...]

Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization

06/11/2024 - 14:00

Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial [...]

PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time

06/11/2024 - 14:00

PRINCETON, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]

Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference

06/11/2024 - 14:00

THE WOODLANDS, Texas, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies London Global Healthcare Conference. Lexicon management including [...]

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

06/11/2024 - 14:00

LEXINGTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel [...]

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

06/11/2024 - 14:00

CUPERTINO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]